Communication
International collaborations and missions
The latest international news, collaborations, events, and missions in life sciences and health.
EMA to relocate to Amsterdam, the Netherlands
Read more ›
Follow EMA and come to Amsterdam during BIO-Europe Spring 2018
Read more ›
Crossing the ocean with the Global Scale-Up Programme
Read more ›
Arab Health gets orange touch with Holland Pavilion
Read more ›
H~H & TFHC aim to continue a powerful opportunity for the Dutch LSH sector
Read more ›
Follow EMA and come to Amsterdam during BIO-Europe Spring 2018
From 12 to 14 March 2018 one of Europe’s largest and most successful partnering conferences for the biotech and pharmaceutical industry, BIO-Europe Spring, will be heading for Amsterdam. BIO-Europe Spring is the premier springtime partnering conference bringing together international decision makers from biotech, pharma and finance. The conference offers various opportunities to engage with global life sciences partners. And is a perfect opportunity to showcase the USPs of the Dutch Life Sciences & Health sector.
Top Sector Life Sciences & Health (Health~Holland) actively supports the conference as a national partner. During the BIO-Europe in Berlin a collaboration contract with the EBD group, the producer of the BIO-Europe conferences, was signed. Therefore Health~Holland invites all Dutch life sciences and health organisations to submit their ideas to jointly deliver a memorable Dutch experience at BIO-Europe Spring 2018 in Amsterdam.
“Health~Holland is honoured to welcome BIO-Europe Spring 2018 to the Netherlands, a country known for partnerships, innovation and collaboration. Let’s meet, connect and engage during this key partnering conference in Amsterdam,” said Hans Schikan, biotech entrepreneur and Top Team member of Top Sector Life Sciences & Health.
Sponsor opportunities
Health~Holland offers several opportunities to increase your organisation’s visibility at BIO-Europe Spring 2018 in Amsterdam, while strengthening our national presence. We aim to deliver a memorable Dutch experience for the international conference guests and we are inviting you to submit your ideas that will help us accomplish that goal. Here, we list some examples. Feel free to add your own!
Join Health~Holland and seize this opportunity to showcase your organisation! Contact Naomi Vorstermans or Wieteke Wouters for more information.
EMA to relocate to Amsterdam, the Netherlands
The European Medicines Agency (EMA) will relocate to Amsterdam in the Netherlands. The agency is responsible for the approval of medicines on the European market. EMA has to relocate due to the United Kingdom’s decision to withdraw from the EU. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest.
Statement by Wouter Bos, who served as ambassador for Amsterdam’s EMA bid: "Amsterdam scored highly on its proposed premises, easy access, and everything the city has to offer the EMA’s staff. That means Amsterdam is also the right choice for the 500 million Europeans who benefit from the Agency’s work."
Amsterdam was one of 19 offers to host EMA submitted by the Member States at the end of July 2017. Besides a strengthening of the network of the Top Sector Life Sciences & Health there is a significant economic impact. Over 2250 fulltime jobs, €150 million direct expenditure and many incoming visitors.
EMA and the Netherlands will kick start their collaboration by establishing a joint governance structure to steer and oversee the relocation project. Because of its important role to safeguard public and animal health in the EU, EMA is committed to giving stakeholders and the public full visibility of the relocation project. In early December, the Agency will make available a monitoring chart on its website that will allow to track the progress made.
Response from the Minister for Healthcare, Bruno Bruins: "This is good news for all patients across Europe. In Amsterdam the EMA will be able to continue its important work without interruption after Brexit. The Agency can continue to grant access to new, innovative medicines without delay and will still be able to respond quickly and effectively in the event of problems with a given drug. Both aspects of the EMA’s role are crucial for all patients in Europe, and we are delighted that the EU made its choice on that basis. I want to thank everyone who contributed to this fine achievement. Now, the real work begins. Amsterdam and the Netherlands as a whole are fully committed to ensuring the EMA’s relocation runs smoothly. We are ready to get started and we will make sure that the EMA’s important work is not disrupted."
Source: EMA and Topsectoren
Arab Health gets orange touch with Holland Pavilion
From 29 January to 1 February 2018, the Task Force Health Care (TFHC) will organise a Holland Pavilion at Arab Health in Dubai for the 7th time. Arab Health is the leading medical trade fair for the Gulf region and the largest gathering of healthcare and trade professionals in the MENA region. The 2018 edition of the event is expected to welcome more than 4,200 exhibiting companies and 103,000 delegates from 150+ countries. Participants at the Holland Pavilion have the opportunity to promote their products and services and to receive international guests. To further capitalise on business opportunities within the Gulf region TFHC has developed a specialised platform; TFHC Middle East.
TFHC Middle East consists of Dutch partners from knowledge institutes and industry working in close cooperation with the Ministry of Health and the Dutch Embassies in the region. The platform has been created to combine Dutch strengths in the Life Sciences & Health sector and to sustain and improve the relationship with the countries in the Middle East.
Crossing the ocean with the Global Scale-Up Programme
End of October the first module of the Global Scale Up Programme (GSP) took place. This programme provides a mentoring pathway that pushes the global business strategy of scale-ups to successful market launch. After a festive kick-off event in Rotterdam earlier this year, eight selected Life Sciences and MedTech scale-ups went on a tour to the United States to meet up with potential investors and partners.
Boston, New York & San Diego
The international business trip started in Boston where the teams were guests at Cambridge Innovation Center (CIC) and were prepped for their investor meetings by a strategic review panel of seasoned entrepreneurs from the Boston Ecosystem. The next day was all about pitching for investors, with a VC breakfast in the morning and a Shark Tank session for VCs and business angels in the afternoon. The next stop of the trip was New York for a training session on communication strategy followed by the OktoberInvestFest for more investor meetings. After New York the programme continued in San Diego with a pitch session for local investors, a business development workshop and a visit to JLabs, part of Johnson & Johnson Innovation. The final destination was Irvine, for a session with the OCTANe Launchpad panel and a marketing panel that provided the teams with valuable input and connections and prepared them for the Medical Technology Innovation Forum (MTIF). All in all, this was a very packed nine days in which the participants interacted with many investors, entrepreneurs and other experts who provided them with valuable lessons, tips and connections to further grow their business towards the US market.
Do you want to participate?
The next module of GSP is already approaching and will take place from 31 January until 1 February 2018 with a module on venture growth and leadership followed by the global investor forum at the Innovation For Health on 1 February 2018. Apply here!
The Global Scale-Up Programme is supported by the Top Sector Life Sciences & Health and is also part of the Life Sciences Business Education Roadmap.
Health~Holland & Task Force Health Care looking to renew a powerful opportunity for the Dutch Life Sciences & Health sector in 2018
In 2017 the Task Force Health Care organised the ‘The International Visitors Programme (IVP)’. The IVP consisted of a 3-day programme, which allowed 110 high level decision-makers (from 10 different countries) in healthcare to visit and share knowledge with health stakeholders in the Netherlands. Stay tuned for the IVP 2018!
Participants in 2017 enjoyed the opportunity to meet fellow Dutch professionals who share the same passion and face similar challenges in healthcare. Besides collective visits to a large number of Dutch institutions and organisations such as; Erasmus Medical Centre on the anticipating trends in healthcare, Radboud University Medical Centre on eHealth data interoperability and hospital build innovation, Buurtzorg on homecare and workshops with the Ministry of Health, Welfare and Sports on public health and elderly care, the various delegations visited the World of Health Care 2017 (WoHC).
The programme benefitted the delegates who were able to compare policies and procedures, structures, solutions and create partnership opportunities to foster improvement. Their attendance at the WoHC marked an annual highlight for the Dutch life sciences & health sector. Around 680 key stakeholders consisting of industry, knowledge institutes, NGO’s, healthcare providers and the government were connected to the 110 high level decision makers in international health from Belgium, Brazil, China, Germany, Kenya, Ukraine, Poland, South Africa, United Arab Emirates and the United States of America.
Health~Holland and the Task Force Health Care are looking at possibilities to set up the International Visitors Programme 2018. Stay tuned for more information!
Health~Holland & TFHC aim to continue a powerful opportunity for the Dutch Life Sciences & Health sector in 2018
In 2017, Task Force Health Care (THFC) organised the ‘The International Visitors Programme (IVP)’. The IVP consisted of a 3-day programme, which allowed 110 high-level decision-makers (from 10 different countries) in healthcare to visit and share knowledge with health stakeholders in the Netherlands. Stay tuned for IVP 2018!
Participants in 2017 enjoyed the opportunity to meet fellow Dutch professionals who share the same passion and face similar challenges in healthcare. There were joint visits to a large number of Dutch institutions and organisations such as Erasmus Medical Centre (anticipating trends in healthcare), Radboud University Medical Centre (eHealth data interoperability and hospital building innovation), Buurtzorg (homecare) and the Ministry of Health, Welfare and Sport (workshops on public health and elderly care). Furthermore, the various delegations visited the World of Health Care 2017 (WoHC).
The programme enabled the delegates to compare policies and procedures, structures and solutions, and create partnership opportunities to foster improvement. Their attendance at the World of Health Care event marked an annual highlight for the Dutch Life Sciences & Health sector. Around 680 key stakeholders from industry, knowledge institutes, NGOs, healthcare providers and the government were connected to the 110 high-level decision makers in international health from Belgium, Brazil, China, Germany, Kenya, Ukraine, Poland, South Africa, the United Arab Emirates and the United States of America.
The great success of the IVP of 2017 has encouraged the organising committee, to increase the opportunities for participants in 2018. Follow our news items and be part of an even bigger programme for international delegations in 2018.